Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Genmab
company
About
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
- 501 - 1000
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $40.50M
- Industries
- Biotechnology,Health Care,Manufacturing,Medical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$42.50M
Genmab has raised a total of
$42.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 13, 2000 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 13, 2000 | Series Unknown | $40.50M | 2 | — | — | Detail |
| May 17, 1999 | Series Unknown | $2M | 1 |
BankInvest Biomedical Venture
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Genmab is funded by 2 investors.
LODH Immunology Fund
and BankInvest Biomedical Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
BankInvest Biomedical Venture
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
